In vivo biological effects of foam sclerotherapy

European Journal of Vascular and Endovascular Surgery

Volumn 42, Issue 2, 2011, Pages 238-245

  Hamel Desnos, C M ^a   Desnos, P R ^a   Ferre, B ^b   Le Querrec, A ^b  

^a Saint Martin Private Hospital   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Coagulation and inflammation markers; Compression sclerotherapy; Peripheral blood; Troponin; Ultrasound guided foam sclerotherapy; Varicose veins

Indexed keywords

AETOXISCLEROL; ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 8; D DIMER; FIBRINOGEN; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SCLEROSING AGENT; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4; THROMBOMODULIN; TROPONIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPRESSION GARMENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; LEG THROMBOSIS; LUNG EMBOLISM; MALE; NECROSIS; NEUROLOGIC DISEASE; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SAPHENOUS VEIN; SCLEROTHERAPY; SINUSITIS; SORE THROAT; THROMBOPHLEBITIS; TREATMENT DURATION; VEIN OCCLUSION;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD COAGULATION; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; FEMALE; FRANCE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SAPHENOUS VEIN; SCLEROSING SOLUTIONS; SCLEROTHERAPY; STOCKINGS, COMPRESSION; TIME FACTORS; TREATMENT OUTCOME; VENOUS INSUFFICIENCY;

EID: 79960945714     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2011.03.034     Document Type: Article

References (19)

1. W. Mol, H. Furukawa, S. Sasaki, U. Tomaru, T. Hayashi, and A. Saito Evaluation of the sclerotherapeutic efficacy of ethanol, polidocanol, and OK-432 using an in vitro model Dermatol Surg 33 2007 1452 1459 (Pubitemid 350212681)
2. K. Parsi, T. Exner, D.E. Connor, D.D.F. Ma, and J.E. Joseph In vitro effects of detergent sclerosants on coagulation, platelets and microparticles Eur J Vasc Endovasc Surg 34 2007 731 740 (Pubitemid 350056374)
3. K. Parsi, T. Exner, J. Low, D. Dang Fung Ma, and J.E. Joseph In vitro effects of detergent sclerosants on antithrombotic mechanisms Eur J Vasc Endovasc Surg 38 2009 220 228
4. J.C. Wollmann Schaum-zwisken Vergangenheit und Zukunft. 8. Bonner Venentage 15-16 Feb 2002 Vasomed 16 1 2002 34 35
5. A. Ikponmwosa, C. Abbott, A. Graham, S. Homer-Vanniasinkam, and M.J. Gough The impact of different concentrations of sodium tetradecyl sulphate and initial balloon denudation on endothelial cell loss and tunica media injury in a model of foam sclerotherapy Eur J Vasc Endovasc Surg 39 2010 366 371
6. X. Jia, G. Mowatt, J.M. Burr, K. Cassar, J. Cook, and C. Fraser Systematic review of foam sclerotherapy for varicose veins Br J Surg 94 2007 925 936 (Pubitemid 47236534)
7. N. Sylvoz, C. Villier, S. Blaise, C. Seinturier, and M. Mallaret Toxicité cardiaque du polidocanol: rapport d'un cas et revue de la littérature J Mal Vasc 33 2008 234 238
8. S. Kundu, F. Lutire, S.F. Millward, F. Padberg, S. Vedantham, and S. Elias Recommended reporting standards for endovenous ablation for the treatment of venous insufficiency: joint statement of the American venous forum and The society of interventional radiology J Vasc Interv Radiol 18 2007 1073 1080 (Pubitemid 47332237)
9. C. Hamel-Desnos, P. Ouvry, J.-P. Bénigni, G. Boitelle, M. Schadeck, P. Desnos, and F.-A. Allaert Comparison of 1% and 3% polidocanol foam in ultrasound-guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 study" Eur J Vasc Endovasc Surg 34 2007 723 729 (Pubitemid 350056378)
10. F.X. Breu, and S. Guggenbichler European consensus meeting on foam sclerotherapy, April, 4-6, 2003, Tegernsee, Germany Dermatol Surg 30 2004 709 717 (Pubitemid 38657961)
11. C. Hamel-Desnos, G. Guias, S. Jousse, P. Desnos, and L. Bressollette Echosclérothérapie la mousse par ponction-injection directe l'aiguille: techniques et doses J Mal Vasc 31 2006 180 189
12. Haute Autorité de Santé Etude d'évaluation des technologies de santé. Evaluation des dispositifs de compression médicale usage individuel - Utilisation en pathologies vasculaires Septembre 2010 http://www.has-sante.fr/portail/jcms/c-937492/evaluation-des- dispositifs-de-compression-medicale-a-usage-individuel-utilisation-en- pathologies-vasculaires
13. C.-K. Oh, D.-S. Jung, H.-S. Jang, and K.-S. Kwon Endovenous laser surgery of the incompetent greater saphenous vein with a 980-nm diode laser Dermatol Surg 29 2003 1135 1140 (Pubitemid 37370446)
14. G. Hinterhuber, K. Bölher, H. Kittler, and P. Quehenberger Extended monitoring of hemostatic activation after varicose vein surgery under general anesthesia Dermatol Surg 32 2006 632 639 (Pubitemid 43742524)
15. M. Ikeda, J. Kambayashi, S. Iwamoto, N. Shinoki, T. Nakamura, and K. Okahara Hemostasis activation during sclerotherapy of lower extremity varices Thromb Res. 82 1 1996 87 95 (Pubitemid 26148563)
16. H. Ariyoshi, J. Kambayashi, S. Tominaga, and T. Hatanaka The possible risk of lower-limb sclerotherapy causing an extended hypercoagulate state Surg Today 26 5 1996 323 327 (Pubitemid 26184217)
17. H. Ljungnér, D. Bergqvist, and I.M. Nilsson Effect of intermittent pneumatic and graduated static compression on factor VIII and the fibrinolytic system Acta Chir Scand 147 1981 657 661 (Pubitemid 12222949)
18. J.L. Gillet, A. Donnet, M. Lausecker, J.M. Guedes, J.J. Guex, and P. Lehman Pathophysiology of visual disturbances occurring after foam sclerotherapy Phlebology 25 2010 261 266
19. J.D. Peterson, and M.P. Goldman An investigation into the influence of various gases and concentrations of sclerosants on foam stability Dermatol Surg 37 2011 12 18 Commentary. Frullini A